<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33977626</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1742-1241</ISSN><JournalIssue CitedMedium="Internet"><Volume>75</Volume><Issue>10</Issue><PubDate><Year>2021</Year><Month>Oct</Month></PubDate></JournalIssue><Title>International journal of clinical practice</Title><ISOAbbreviation>Int J Clin Pract</ISOAbbreviation></Journal><ArticleTitle>Frequency, signs and symptoms, and criteria adopted for long COVID-19: A systematic review.</ArticleTitle><Pagination><StartPage>e14357</StartPage><MedlinePgn>e14357</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e14357</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1111/ijcp.14357</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">To identify, systematically evaluate and summarise the best available evidence on the frequency of long COVID-19 (post-acute COVID-19 syndrome), its clinical manifestations, and the criteria used for diagnosis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Systematic review conducted with a comprehensive search including formal databases, COVID-19 or SARS-CoV-2 data sources, grey literature, and manual search. We considered for inclusion clinical trials, observational longitudinal comparative and non-comparative studies, cross-sectional, before-and-after, and case series. We assessed the methodological quality by specific tools based on the study designs. We presented the results as a narrative synthesis regarding the frequency and duration of long COVID-19, signs and symptoms, criteria used for diagnosis, and potential risk factors.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We included 25 observational studies with moderate to high methodological quality, considering 5440 participants. The frequency of long COVID-19 ranged from 4.7% to 80%, and the most prevalent signs/symptoms were chest pain (up to 89%), fatigue (up to 65%), dyspnea (up to 61%), and cough and sputum production (up to 59%). Temporal criteria used to define long COVID-19 varied from 3 to 24&#xa0;weeks after acute phase or hospital discharge. Potentially associated risk factors were old age, female sex, severe clinical status, a high number of comorbidities, hospital admission, and oxygen supplementation at the acute phase. However, limitations related to study designs added uncertainty to this finding. None of the studies assessed the duration of signs/symptoms.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The frequency of long COVID-19 reached up to 80% over the studies included and occurred between 3 and 24&#xa0;weeks after acute phase or hospital discharge. Chest pain, fatigue, dyspnea, and cough were the most reported clinical manifestations attributed to the condition. Based on these systematic review findings, there is an urgent need to understand this emerging, complex and challenging medical condition. Proposals for diagnostic criteria and standard terminology are welcome.</AbstractText><CopyrightInformation>&#xa9; 2021 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cabrera Martimbianco</LastName><ForeName>Ana Luiza</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>N&#xfa;cleo de Avalia&#xe7;&#xe3;o de Tecnologias em Sa&#xfa;de, Hospital S&#xed;rio-Liban&#xea;s (HSL), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Pesquisa M&#xe9;dica, Centro Universit&#xe1;rio S&#xe3;o Camilo (CUSC), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Postgraduate program in health and environmental, Universidade Metropolitana de Santos (Unimes), Santos, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Oxford-Brazil EBM Alliance, Oxford-Brazil EBM Alliance, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pacheco</LastName><ForeName>Rafael Leite</ForeName><Initials>RL</Initials><Identifier Source="ORCID">0000-0001-7487-8471</Identifier><AffiliationInfo><Affiliation>N&#xfa;cleo de Avalia&#xe7;&#xe3;o de Tecnologias em Sa&#xfa;de, Hospital S&#xed;rio-Liban&#xea;s (HSL), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Pesquisa M&#xe9;dica, Centro Universit&#xe1;rio S&#xe3;o Camilo (CUSC), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Oxford-Brazil EBM Alliance, Oxford-Brazil EBM Alliance, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bagattini</LastName><ForeName>&#xc2;ngela Maria</ForeName><Initials>&#xc2;M</Initials><AffiliationInfo><Affiliation>N&#xfa;cleo de Avalia&#xe7;&#xe3;o de Tecnologias em Sa&#xfa;de, Hospital S&#xed;rio-Liban&#xea;s (HSL), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Patologia Tropical e Sa&#xfa;de P&#xfa;blica, Universidade Federal de Goi&#xe1;s (UFG), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riera</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>N&#xfa;cleo de Avalia&#xe7;&#xe3;o de Tecnologias em Sa&#xfa;de, Hospital S&#xed;rio-Liban&#xea;s (HSL), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Oxford-Brazil EBM Alliance, Oxford-Brazil EBM Alliance, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Escola Paulista de Medicina, Universidade Federal de S&#xe3;o Paulo (Unifesp), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Sociedade Beneficente de Senhoras Hospital S&#xed;rio-Liban&#xea;s</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Clin Pract</MedlineTA><NlmUniqueID>9712381</NlmUniqueID><ISSNLinking>1368-5031</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>12</Day><Hour>7</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33977626</ArticleId><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="doi">10.1111/ijcp.14357</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Greenhalgh T, Knight M, A'Court C, Buxton M, Husain L. Management of post&#x2010;acute covid&#x2010;19 in primary care. BMJ. 2020;370:m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Landi F, Carf&#xec; A, Benvenuto F, et al. Predictive factors for a new positive nasopharyngeal swab among patients recovered from covid&#x2010;19. Am J Prev Med. 2021;60(1):13&#x2010;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7500946</ArticleId><ArticleId IdType="pubmed">33041095</ArticleId></ArticleIdList></Reference><Reference><Citation>Gemelli Against COVID&#x2010;19 Post&#x2010;Acute Care Study Group . Post&#x2010;COVID&#x2010;19 global health strategies: the need for an interdisciplinary approach. Aging Clin Exp Res. 2020;32(8):1613&#x2010;1620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7287410</ArticleId><ArticleId IdType="pubmed">32529595</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F; Gemelli against COVID&#x2010;19 Post&#x2010;Acute Care Study Group . Persistent symptoms in patients after acute COVID&#x2010;19. JAMA. 2020;324(6):603&#x2010;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID&#x2010;19 in a multistate Health Care Systems Network &#x2013; United States, March&#x2010;June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993&#x2010;998.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>
Higgins JPT, Thomas J, Chandler J, et al. ,editors. Cochrane handbook for systematic reviews of interventions version 6.0 (updated July 2019). www.training.cochrane.org/handbook. Accessed January 29, 2021.</Citation></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group . Preferred reporting items for systematic reviews and meta&#x2010;analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan&#x2010;a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5139140</ArticleId><ArticleId IdType="pubmed">27919275</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Hern&#xe1;n MA, Reeves BC, et al. ROBINS&#x2010;I: a tool for assessing risk of bias in non&#x2010;randomized studies of interventions. BMJ. 2016;355:i4919.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5062054</ArticleId><ArticleId IdType="pubmed">27733354</ArticleId></ArticleIdList></Reference><Reference><Citation>
Joanna Briggs Institute
. Checklist for cross sectional studies. https://jbi.global/sites/default/files/2019&#x2010;05/JBI_Critical_Appraisal&#x2010;Checklist_for_Analytical_Cross_Sectional_Studies2017_0.pdf. Accessed January 29, 2021.</Citation></Reference><Reference><Citation>
Joanna Briggs Institute
. Checklist for prevalence studies. 2017. https://joannabriggs.org/sites/default/files/2019&#x2010;05/JBI_Critical_Appraisal&#x2010;Checklist_for_Prevalence_Studies2017_0.pdf. Accessed January 29, 2021.</Citation></Reference><Reference><Citation>
National Institute of Health
. Quality assessment tool for case series studies. https://www.nhlbi.nih.gov/health&#x2010;topics/study&#x2010;quality&#x2010;assessment&#x2010;tools. Accessed June 30, 2020.</Citation></Reference><Reference><Citation>Deisenhammer F, Borena W, Bauer A, et al. 6&#x2010;month SARS&#x2010;CoV&#x2010;2 antibody persistency in a Tyrolian COVID&#x2010;19 cohort. Wien Klin Wochenschr. 2020;9:1&#x2010;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E, Rushforth A, Wieringa S, et al. Developing services for long COVID: lessons from a study of wounded healers. Clin Med (Lond). 2021;21(1):59&#x2010;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850205</ArticleId><ArticleId IdType="pubmed">33479069</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao B, Liu Z, Tang L, et al. Longitudinal clinical and radiographic evaluation reveals interleukin&#x2010;6 as an indicator of persistent pulmonary injury in COVID&#x2010;19. Int J Med Sci. 2021;18(1):29&#x2010;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7738960</ArticleId><ArticleId IdType="pubmed">33390771</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, et al. Autonomic dysfunction in &#x2018;long COVID&#x2019;: rationale, physiology and management strategies. Clin Med (Lond). 2021;21(1):e63&#x2010;e67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu JWTW, de Luca RD, Mello Neto HO, Barcellos I. Post&#x2010;COVID&#x2010;19 syndrome? New daily persistent headache in the aftermath of COVID&#x2010;19. Arq Neuropsiquiatr. 2020;78(11):753&#x2010;754.</Citation><ArticleIdList><ArticleId IdType="pubmed">33331469</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E, Rushforth A, Wieringa S, et al. Persistent symptoms after Covid&#x2010;19: qualitative study of 114 &#x201c;long Covid&#x201d; patients and draft quality principles for services. BMC Health Serv Res. 2020;20(1):1144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Zheng C, Duan C, et al. Rehabilitation needs of the first cohort of post&#x2010;acute COVID&#x2010;19 patients in Hubei, China. Eur J Phys Rehabil Med. 2020;56(3):339&#x2010;344.</Citation><ArticleIdList><ArticleId IdType="pubmed">32672029</ArticleId></ArticleIdList></Reference><Reference><Citation>Sofian M, Velayati AA, Banifazl M, et al. SARS&#x2010;CoV&#x2010;2, a virus with many faces: a series of cases with prolonged persistence of COVID&#x2010;19 symptoms. Wien Med Wochenschr. 2021;171(1&#x2013;2):3&#x2010;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7734614</ArticleId><ArticleId IdType="pubmed">33315163</ArticleId></ArticleIdList></Reference><Reference><Citation>Rovere Querini P, De Lorenzo R, Conte C, et al. Post&#x2010;COVID&#x2010;19 follow&#x2010;up clinic: depicting chronicity of a new disease. Acta Biomed. 2020;91(9&#x2010;S):22&#x2010;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023087</ArticleId><ArticleId IdType="pubmed">32701913</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh SJ, Barradell AC, Greening NJ, et al. British Thoracic Society survey of rehabilitation to support recovery of the post&#x2010;COVID&#x2010;19 population. BMJ Open. 2020;10(12):e040213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7712930</ArticleId><ArticleId IdType="pubmed">33268418</ArticleId></ArticleIdList></Reference><Reference><Citation>Thai PQ, Toan DTT, Son DT, et al. Factors associated with the duration of hospitalization among COVID&#x2010;19 patients in Vietnam: a survival analysis. Epidemiol Infect. 2020;10(148):e114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7306545</ArticleId><ArticleId IdType="pubmed">32517822</ArticleId></ArticleIdList></Reference><Reference><Citation>Vink M, Vink&#x2010;Niese A. Could cognitive behavioural therapy be an effective treatment for long COVID and post COVID&#x2010;19 fatigue syndrome? Lessons from the Qure study for Q&#x2010;fever fatigue syndrome. Healthcare (Basel). 2020;8(4):552.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7764131</ArticleId><ArticleId IdType="pubmed">33322316</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Soddu D, Balbo PE, et al. Respiratory and psychophysical sequelae among patients with COVID&#x2010;19 four months after hospital discharge. JAMA Netw Open. 2021;4(1):e2036142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841464</ArticleId><ArticleId IdType="pubmed">33502487</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho&#x2010;Schneider C, Laurent E, Lemaignen A, et al. Follow&#x2010;up of adults with noncritical COVID&#x2010;19 two months after symptom onset. Clin Microbiol Infect. 2021;27(2):258&#x2010;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>El Sayed S, Shokry D, Gomaa SM. Post&#x2010;COVID&#x2010;19 fatigue and anhedonia: a cross&#x2010;sectional study and their correlation to post&#x2010;recovery period. Neuropsychopharmacol Rep. 2021;41(1):50&#x2013;55. 10.1002/npr2.12154</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/npr2.12154</ArticleId><ArticleId IdType="pmc">PMC8182964</ArticleId><ArticleId IdType="pubmed">33332756</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, et al. Post&#x2010;discharge persistent symptoms and health&#x2010;related quality of life after hospitalization for COVID&#x2010;19. J Infect. 2020;81(6):e4&#x2010;e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Campion JY, Dudouet P, et al. 18F&#x2010;FDG brain PET hypometabolism in patients with long. Eur J Nucl Med Mol Imaging. 2021;1&#x2010;11. 10.1007/s00259-021-05215-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID&#x2010;19 infection: a cross&#x2010;sectional evaluation. J Med Virol. 2021;93(2):1013&#x2010;1022.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6&#x2010;month consequences of COVID&#x2010;19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2010;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs LG, Gourna Paleoudis E, Lesky&#x2010;Di Bari D, et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID&#x2010;19 infection. PLoS One. 2020;15(12):e0243882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7732078</ArticleId><ArticleId IdType="pubmed">33306721</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang L, Yang B, Jiang N, et al. Three&#x2010;month follow&#x2010;up study of survivors of coronavirus disease 2019 after discharge. J Korean Med Sci. 2020;35(47):e418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7721559</ArticleId><ArticleId IdType="pubmed">33289374</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Li X, Geng D, et al. Cerebral micro&#x2010;structural changes in COVID&#x2010;19 patients &#x2013; an MRI&#x2010;based 3&#x2010;month follow&#x2010;up study. EClinicalMedicine. 2020;25:100484.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno&#x2010;P&#xe9;rez O, Merino E, Leon&#x2010;Ramirez JM, et al. Post&#x2010;acute COVID&#x2010;19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infect. 2021;S0163&#x2013;4453(21):9&#x2010;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M, Braillard O, Alcoba G, et al. COVID&#x2010;19 symptoms: longitudinal evolution and persistence in outpatient settings. Ann Intern Med. 2020;174(5):723&#x2010;725.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7741180</ArticleId><ArticleId IdType="pubmed">33284676</ArticleId></ArticleIdList></Reference><Reference><Citation>Otte MS, Eckel HNC, Poluschkin L, Klussmann JP, Luers JC. Olfactory dysfunction in patients after recovering from COVID&#x2010;19. Acta Otolaryngol. 2020;140(12):1032&#x2010;1035.</Citation><ArticleIdList><ArticleId IdType="pubmed">32852240</ArticleId></ArticleIdList></Reference><Reference><Citation>Otte MS, Klussmann JP, Luers JC. Persisting olfactory dysfunction in patients after recovering from COVID&#x2010;19. J Infect. 2020;81(3):e58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7313498</ArticleId><ArticleId IdType="pubmed">32592702</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen MS, Kristiansen MF, Hanusson KD, et al. Long COVID in the Faroe Islands: a longitudinal study among nonhospitalized patients. Clin Infect Dis. 2020;ciaa1792. 10.1093/cid/ciaa1792</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Puchner B, Sahanic S, Kirchmair R, et al. Beneficial effects of multi&#x2010;disciplinary rehabilitation in post&#x2010;acute COVID&#x2010;19 &#x2013; an observational cohort study. Eur J Phys Rehabil Med. 2021;57(2):189&#x2010;198.</Citation><ArticleIdList><ArticleId IdType="pubmed">33448756</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramani C, Davis EM, Kim JS, Provencio JJ, Enfield KB, Kadl A. Post&#x2010;ICU COVID&#x2010;19 outcomes: a case series. Chest. 2021;159(1):215&#x2010;218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7442057</ArticleId><ArticleId IdType="pubmed">32835708</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosales&#x2010;Castillo A, de Los G, R&#xed;os C, Mediavilla Garc&#xed;a JD. Persistent symptoms after acute COVID&#x2010;19 infection: importance of follow&#x2010;up. Persistencia de manifestaciones cl&#xed;nicas tras la infecci&#xf3;n COVID&#x2010;19: importancia del seguimiento. Med Clin (Barc). 2021;156(1):35&#x2010;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7518172</ArticleId><ArticleId IdType="pubmed">33077167</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth NC, Kim A, Vitkovski T, et al. Post&#x2010;COVID&#x2010;19 Cholangiopathy: a novel entity. Am J Gastroenterol. 2021;116(5):1077&#x2013;1082.</Citation><ArticleIdList><ArticleId IdType="pubmed">33464757</ArticleId></ArticleIdList></Reference><Reference><Citation>Simani L, Ramezani M, Darazam IA, et al. Prevalence and correlates of chronic fatigue syndrome and post&#x2010;traumatic stress disorder after the outbreak of the COVID&#x2010;19. J Neurovirol. 2021;27(1):154&#x2010;159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7852482</ArticleId><ArticleId IdType="pubmed">33528827</ArticleId></ArticleIdList></Reference><Reference><Citation>Su&#xe1;rez&#x2010;Robles M, Iguaran&#x2010;Berm&#xfa;dez MDR, Garc&#xed;a&#x2010;Klepizg JL, Lorenzo&#x2010;Villalba N, M&#xe9;ndez&#x2010;Bail&#xf3;n M. Ninety days post&#x2010;hospitalization evaluation of residual COVID&#x2010;19 symptoms through a phone call check list. Pan Afr Med J. 2020;37:289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7881918</ArticleId><ArticleId IdType="pubmed">33654513</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarazona&#x2010;Fern&#xe1;ndez A, Rauch&#x2010;S&#xe1;nchez E, Herrera&#x2010;Alanua O, Gal&#xe1;n&#x2010;Rodas E. &#xbf;Enfermedad prolongada o secuela pos&#x2010;COVID&#x2010;19? Prolonged disease or post&#x2010;COVID&#x2010;19 sequela? Acta Med Peru. 2020;37(4):565&#x2010;567. 10.35663/amp.2020.374.18669</Citation><ArticleIdList><ArticleId IdType="doi">10.35663/amp.2020.374.18669</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Borst B, Peters JB, Brink M, et al. Comprehensive health assessment three months after recovery from acute COVID&#x2010;19. Clin Infect Dis. 2020. 10.1093/cid/ciaa1750</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1750</ArticleId><ArticleId IdType="pmc">PMC7717214</ArticleId><ArticleId IdType="pubmed">33220049</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q, Xu M, Li J, et al. Clinical sequelae of COVID&#x2010;19 survivors in Wuhan, China: a single&#x2010;centre longitudinal study. Clin Microbiol Infect. 2021;27(1):89&#x2010;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao YM, Shang YM, Song WB, et al. Follow&#x2010;up study of the pulmonary function and related physiological characteristics of COVID&#x2010;19 survivors three months after recovery. EClinicalMedicine. 2020;25:100463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post&#x2010;acute COVID&#x2010;19 syndrome. Nat Med. 2021;27(4):601&#x2010;615. 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>